ArticleFrontiers in microbiology2018
Pentocin MQ1: A Novel, Broad-Spectrum, Pore-Forming Bacteriocin From
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 58 citations in OpenAlex.
- Current Status and Future Challenges in the Use of Bacteriocins to Modulate Ruminant Gut Microbiota.Probiotics and antimicrobial proteins · 2026Review
- The Antibacterial Effect and Mechanism of a Bacteriocin Produced byJournal of microbiology and biotechnology · 2025Article
- A Review on Bacteriocin Extraction Techniques from Lactic Acid Bacteria.Probiotics and antimicrobial proteins · 2025Review
- Article
- Mitigating gut dysbiosis induced by biofilm-forming pathogens: therapeutic potential of LAB-derived bacteriocins.Frontiers in microbiology · 2025Article
- Antimicrobial activity ofPeerJ · 2025Article
- Bacteriocin Mining inFoods (Basel, Switzerland) · 2024Article
- Cholesterol-Lowering Activity ofJournal of microbiology and biotechnology · 2024Article
- The clinical praxis of bacteriocins as natural anti-microbial therapeutics.Archives of microbiology · 2024Review
- A novel bacteriocin against multiple foodborne pathogens fromCurrent research in food science · 2023Article
- Antibacterial Effect of Cell-Free Supernatant fromMolecules (Basel, Switzerland) · 2022Article
- Biological chemotaxis-guided self-thermophoretic nanoplatform augments colorectal cancer therapy through autonomous mucus penetration.Science advances · 2022Article
- Bacteriocins: Properties and potential use as antimicrobials.Journal of clinical laboratory analysis · 2022Review
- Isolation, Characterization, and Effect on Biofilm Formation of Bacteriocin Produced byBioMed research international · 2022Article
- CBP22, a Novel Bacteriocin Isolated fromMediators of inflammation · 2021Article
- A Novel Bacteriocin AgainstFrontiers in microbiology · 2021Article
- A Novel Bacteriocin FromFrontiers in nutrition · 2021Article
- Characterization, modes of action, and application of a novel broad-spectrum bacteriocin BM1300 produced by Lactobacillus crustorum MN047.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2020Article
- Partial purification and characterization of a broad-spectrum bacteriocin produced by aFood science & nutrition · 2020Article
- Competitive and/or Cooperative Interactions ofFrontiers in microbiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.